Evaluation of nutrition, immunology and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent and nutritional care

Evaluation of nutrition, immunology and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent and nutritional care - GLSG, 2006, nutrition

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000398

Enrollment

Registered

2012-04-01

Start date

2005-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Interventions

aminolevan EN

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Liver cirrhosis (child B) the patients with insufficient elevation of serum albumin value by administration of BCAA granules

Exclusion criteria

Exclusion criteria: the patients with regularly administration of albumin, administration of other oral amino-acid agents, renal dysfunction, congenital amino-acid metabolic dysfunction, cirrhosis by autoimmune mechanism, scheduled treatment of varices within 3 months, with uncontrollable ascites

Design outcomes

Primary

Measure	Time frame
cell immunity	—

Secondary

Measure	Time frame
morbidity safety	—

Countries

Japan

Contacts

Public ContactKen Sato

Gunma University Graduate School of medicine Department of Medicine and Molecular Science

satoken@gunma-u.ac.jp027-220-8127

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026